Onderneming ACADIA Pharmaceuticals Inc.
Aandelen
ACAD
US0042251084
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
16,71 USD | +2,45% | -0,65% | -46,63% |
Vakgebied
Aantal werknemers: 598
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Innovative Medicines
100,0
%
| 517 | 100,0 % | 726 | 100,0 % | +40,45% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 517 | 100,0 % | 726 | 100,0 % | +40,45% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Davis
CEO | Chief Executive Officer | 63 | 15-07-14 |
Mark Schneyer
DFI | Director of Finance/CFO | 50 | 28-05-20 |
Benir Ruano
CTO | Chief Tech/Sci/R&D Officer | - | 01-11-22 |
Sanjeev Pathak
CTO | Chief Tech/Sci/R&D Officer | - | 01-03-21 |
Brendan Teehan
COO | Chief Operating Officer | 56 | 01-07-18 |
Ponni Subbiah
CTO | Chief Tech/Sci/R&D Officer | - | 01-10-19 |
- | - | ||
Kimberly Manhard
PRN | Corporate Officer/Principal | 64 | 30/01 |
Kevin Oliver
PRN | Corporate Officer/Principal | - | 10-07-23 |
Holly Valdiviez
SAM | Sales & Marketing | - | 01-04-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Julian Baker
BRD | Director/Board Member | 57 | 11-12-15 |
Edmund Harrigan
BRD | Director/Board Member | 71 | 25-11-15 |
Stephen Davis
CEO | Chief Executive Officer | 63 | 15-07-14 |
Don Soland
BRD | Director/Board Member | 65 | 20-03-15 |
Laura Brege
BRD | Director/Board Member | 66 | 01-05-08 |
Stephen Biggar
CHM | Chairman | 53 | 22-01-13 |
James Daly
BRD | Director/Board Member | 63 | 11-01-16 |
Director/Board Member | 66 | 29-09-20 | |
Adora Ndu
BRD | Director/Board Member | 43 | 10-10-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 164 771 521 | 163 859 371 ( 99,45 %) | 0 | 99,45 % |
Bedrijfsgegevens
ACADIA Pharmaceuticals, Inc.
12830 El Camino Real Suite 400
92130-3331, San Diego
+858 558 2871
http://www.acadia.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-46,63% | 2,76 mld. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |
- Beurs
- Aandelen
- Koers ACAD
- Onderneming ACADIA Pharmaceuticals Inc.